Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

7.4%

2 terminated out of 27 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

15%

4 trials in Phase 3/4

Results Transparency

41%

9 of 22 completed with results

Key Signals

9 with results92% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (2)
P 1 (2)
P 2 (7)
P 3 (4)

Trial Status

Completed22
Unknown2
Terminated2
Not Yet Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT07149428Not Yet RecruitingPrimary

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT06482099CompletedPrimary

SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS

NCT06974747Not ApplicableCompletedPrimary

Immunomodulatory Effect of Pleuran in Children With Recurrent Respiratory Tract Infections

NCT06936761CompletedPrimary

This Study Evaluated the Safety of Awake Extubation in Children at Risk for Respiratory Events Undergoing General Anesthesia.

NCT05337163Completed

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

NCT04424316Phase 3CompletedPrimary

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

NCT03524118Phase 1CompletedPrimary

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

NCT04032093Phase 2CompletedPrimary

A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

NCT01789268CompletedPrimary

Impact of Respiratory Pathogens in Infants

NCT03572062Phase 2TerminatedPrimary

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

NCT04071158Phase 2CompletedPrimary

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

NCT00934934Phase 2Terminated

Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment

NCT01787227CompletedPrimary

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

NCT02087761UnknownPrimary

A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients

NCT02568800Phase 3Unknown

Prolonged Infusion Cefepime and Nosocomial Infections

NCT02210156Not ApplicableCompletedPrimary

Effects of a Supplement on Acute Respiratory Infections

NCT01075204CompletedPrimary

Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)

NCT00265187CompletedPrimary

The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis.

NCT01549938Phase 2CompletedPrimary

Cholecalciferol Intervention to Prevent Respiratory Infections Study

NCT00427141Phase 1CompletedPrimary

A Three-Part Study Of GSK580416 In Healthy Subjects

Scroll to load more

Research Network

Activity Timeline